The study of ocular infections and immune responses is critical in managing vision-threatening conditions. Ocular microbiology and immunology focus on pathogens like bacteria, viruses, and fungi that cause conjunctivitis, keratitis, and endophthalmitis. Understanding the eye’s immune privilege is vital for developing targeted therapies that minimize inflammation while combating infection. Recent research highlights the role of the ocular microbiome in maintaining homeostasis and its disruption in disease states. Advances in molecular diagnostics, such as PCR-based assays, enable rapid identification of pathogens, improving treatment precision. Immunomodulatory therapies, including biologics, are emerging as effective options for uveitis and other inflammatory disorders. These insights guide clinicians in optimizing antimicrobial and immunosuppressive strategies, ensuring better prognosis for patients with complex ocular conditions.
Title : Rare and interesting case of Goldenhar’s syndrome in a 3 years old male child
Gowhar Ahmad, Florence Hospital Srinagar, India
Title : Management of common vitreoretinal lesions: An overview and update
Tim Jackson, King’s College London, United Kingdom
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : An advanced 3D human-based in vitro model to identify disease-specific molecular markers of glaucoma neurodegeneration
Anna Maria Bassi, University of Genoa, Italy
Title : Evaluating the quality and readability of AI chatbot responses to frequently asked questions on basal cell carcinoma: Implications for patient education and digital health communication
Arrane Selvamogan, Leicestershire Partnership NHS Trust, United Kingdom
Title : Evaluating the quality and readability of AI-generated ophthalmic surgery education: A four-model comparison
Arrane Selvamogan, Leicestershire Partnership NHS Trust, United Kingdom